Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.

Researchers at the University of Washington have developed a rapid test that quickly detects hepatitis C, but insurance ...

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use ...

An exam meant to determine whether a baby was born dead or alive is of “questionable value,” the National Association of ...

Fulgent Genetics will acquire assets from Bako Diagnostics and StrataDx for $55.5 million in a deal that will expand the company's offering of testing services.

At Health First, this innovation is being brought to life through partners like NextGen Pathology, delivering precise diagnostic services.

Tempus AI, Inc. (NASDAQ:TEM) ranks among the best AI stocks to buy according to analysts. On December 8, TD Cowen reaffirmed ...

A memorandum of understanding (MoU) was signed between the Islamia University of Bahawalpur and Nadeem Khan Pathology ...

“Mental disorders,” in stark contrast, are nominal or classificatory kinds: They are names or descriptions of clusters of ...

In many regions, doctors practice in settings with limited medical resources. Advanced tests, specialist support, and expert ...

Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

Findings show Linus Health’s AI can indicate Alzheimer’s pathology before noticeable symptoms—enabling earlier action to help protect independence and preserve what makes us who we areBOSTON, December ...